Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres

Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia

(2019) Azael Freites-Martinez et al.   JAMA Dermatology

Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)

(2019) Danbee Kang et al.   SUPPORTIVE CARE IN CANCER

Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

(2018) M. Martín et al.   BREAST CANCER RESEARCH AND TREATMENT

Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review

(2018) Belen Rubio-Gonzalez et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Permanent Chemotherapy‐Induced Alopecia in Patients with Breast Cancer: A 3‐Year Prospective Cohort Study

(2018) Danbee Kang et al.   ONCOLOGIST

Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in female cancer patients

(2016) M.K. Fehr et al.   Current Oncology

Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia

(2016) Manon M. C. Komen et al.   SUPPORTIVE CARE IN CANCER

Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil

(2015) Xinyi Yang et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Long-term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial

(2015) D.A. Glaser et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy

(2015) Tessa Cigler et al.   Clinical Breast Cancer

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) E. Senkus et al.   ANNALS OF ONCOLOGY

Pathobiology of chemotherapy-induced hair loss

(2013) Ralf Paus et al.   LANCET ONCOLOGY

Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment

(2013) Daniel C. Betticher et al.   SUPPORTIVE CARE IN CANCER

Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling Registry

(2012) Corina J. van den Hurk et al.   ACTA ONCOLOGICA

Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients

(2012) N. Kluger et al.   ANNALS OF ONCOLOGY

Chemotherapy-induced alopecia

(2011) Susan Y. Chon et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Permanent chemotherapy-induced alopecia: Case report and review of the literature

(2010) Ben Tallon et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer

(2009) C. Prevezas et al.   BRITISH JOURNAL OF DERMATOLOGY

Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis

(2009) Davide Mauri et al.   CANCER TREATMENT REVIEWS

Impact of alopecia and scalp cooling on the well-being of breast cancer patients

(2009) Corina J. G. van den Hurk et al.   PSYCHO-ONCOLOGY

Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations

(2008) Floortje Mols et al.   SUPPORTIVE CARE IN CANCER